Citrate level in osteoporotic women treated with estrogen and alendronate

被引：0
|
作者：
D'Amelio, P
Beccattini, W
Pescarmona, GP
Isaia, GC
机构：
[1] Univ Turin, Dept Gen Biol & Biochem, I-10124 Turin, Italy
[2] Univ Turin, Dept Internal Med, I-10124 Turin, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
374
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] Effects of combined estrogen and alendronate treatments in osteoporotic women
    Manno, R
    Caplan, F
    Christmas, C
    Bellantoni, M
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S43 - S43
  • [2] ATRIAL FIBRILLATION IN OSTEOPOROTIC WOMEN TREATED WITH ALENDRONATE
    Chang, L. C.
    Kao, Y. H.
    Hsiao, F. Y.
    Tsai, Y. W.
    Huang, W. F.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A123 - A123
  • [3] DENOSUMAB COMPARED WITH ALENDRONATE IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ALENDRONATE
    Bernad, M.
    Garces, M.
    Martin Mola, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 768 - 768
  • [4] Quality of life in osteoporotic Turkish women treated with alendronate
    Akyüz, G
    Eskiyurt, N
    Ofluoglu, D
    Aki, S
    Kayhan, O
    Oncel, A
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S170 - S170
  • [5] Femoral strength in osteoporotic women treated with teriparatide or alendronate
    Keaveny, Tony M.
    McClung, Michael R.
    Wan, Xiaohai
    Kopperdahl, David L.
    Mitlak, Bruce H.
    Krohn, Kelly
    [J]. BONE, 2012, 50 (01) : 165 - 170
  • [6] Response to alendronate in osteoporotic women previously treated with pamidronate
    Peretz, A
    Siderova, V
    Body, JJ
    Dumon, JC
    Rozenberg, S
    Fellemans, C
    Fuss, M
    Bergmann, P
    [J]. MATURITAS, 2003, 44 (02) : 111 - 115
  • [7] Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate
    Sebastian-Ochoa, Arantzazu
    Fernandez-Garcia, Diego
    Reyes-Garcia, Rebeca
    Mezquita-Raya, Pedro
    Rozas-Moreno, Pedro
    Alonso-Garcia, Guillermo
    Munoz-Torres, Manuel
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (02): : 172 - 177
  • [8] EVALUATION OF THREE REGIMENS OF CHOLECALCIFEROL DOSING IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN TREATED WITH ALENDRONATE
    Kocjan, Tomaz
    Jensterle, Mojca
    Pfeifer, Marija
    Sabati Rajic, Antonela
    Bajuk Studen, Katica
    Prezelj, Janez
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S286 - S287
  • [9] Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy
    Palomba, S
    Orio, F
    Russo, T
    Colao, A
    Lombardi, G
    Zullo, F
    [J]. FERTILITY AND STERILITY, 2004, 81 (02) : 476 - 478
  • [10] The response of postmenopausal osteoporotic women to alendronate.
    Fairney, A
    Kyd, P
    Kerkhoff, F
    Murphy, M
    Thomas, E
    Wilson, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S467 - S467
12345